Re­silience col­lab­o­rates with the Mayo Clin­ic to man­u­fac­ture rare and com­plex dis­ease drugs

Af­ter net­ting its Se­ries D round of fund­ing in June, Re­silience is not sit­ting around and rest­ing on its lau­rels.

The Bob Nelsen-backed con­tract man­u­fac­tur­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER